We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01138605
Recruitment Status : Completed
First Posted : June 7, 2010
Last Update Posted : January 9, 2018
Information provided by (Responsible Party):
Janssen Sciences Ireland UC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 23, 2017
  Study Completion Date : November 23, 2017